Theme:

Pharmaceutical Chemistry 2021

Renowned Speakers

Pharmaceutical Chemistry 2021

Pharmaceutical Chemistry 2021 is a global overview of  the theme " Advances in the researches in the field of Pharmaceutical Sciences ". It is a pavement for Pharmaceutical Chemistry experts and scientific professionals to explore the research challenges & current trends and unleash advanced strategies in the arena of Pharma and Chemistry research areas. Pharmaceutical Chemistry-2020 is a specially designed cluster conference and would lay a platform for  the interaction among specialists, directors, professors, faculties, experts and research fellows around the world reputed research institutes, universities and companies, agencies, association & societies. It aims in accelerating the scientific discoveries in the field of Pharma and Chemistry to exchange information on their latest research progress. We are glad to have your participation in ‘17th International Conference on Pharmaceutical Chemistry’ to be held during 26-27 July 2021 scheduled in Rome,Italy.  The organizing committee is gearing up for an exciting and informative event procuring plenary lectures, symposium, workshops, Video presentations, poster presentations on a variety of topics and various sessions for participants from all over the world.

For more details please visit- https://pharmaceuticalchemistry.pharmaceuticalconferences.com/

 

TRACK 1: Chem-Corona (Corona-Virus)

Coronaviruses are types of viruses that Usually affect the respiratory tracts of birds and mammals, including homo sapiens. Doctors dealing with them with the common cold, bronchitis, pneumonia, and severe acute respiratory syndrome (SARS). Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus (nCoV) is a new strain that has not been previously identified in homosapiens. Coronaviruses are zoonotic, meaning they can transmit between animals and Humans.  In Depth investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Common signs of infection include respiratory symptoms, fever, and cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth, Sanitization and nose when coughing and sneezing. Maintaining Social Distance with anyone showing symptoms of respiratory illness such as coughing and sneezing.

  • Spike Protein Problems
  • Mutations
  • Types of Drugs To target Spike Protein

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)
 

Track 2: Medchem-Antimicrobial And Infectious Agents

Infectious disease and antimicrobial agent use imply deep knowledge and expertise in this field by medical team and clinical pharmaceutical care principle can complete the clinician’s works in more rational way preserving the activity of some critical drugs from MDR diffusion. We think that using the methods of the researcher in 1800-1900 in their laboratory without a lot of burocratic rules we can obtain more relevant pharmacological molecules to introduce in therapy today. With the Rise in the Population there is a clear rise in Infectious agents also, in order to tackle that we need to focus on advanced techniques, innovative ideas and upcoming Artificial intelligence to counter those Microbes.

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 3: Solid-state pharmaceutical chemistry

Solid-state pharmaceutical chemistry deals with a wide range of concentrates on pharmaceutical solids including (1) getting assured of the physical properties of polymorphs and solvates, (2) physical changes happening among polymorphs and solvates, (3) chemical responses in the solid state, and (4) solid-solid responses which happen in pharmaceutical preparations. Recent advances in this field incorporate improved comprehension of crystallization processes, improved comprehension of the requirement for characterization of polymorphs and solvates for both control and administrative purposes, and a superior comprehension of the mechanisms of solid state degradations and solid-solid reactions.

  • Polymorph Conversion
  •  Polymorph Prediction
  •  Pharmaceutical Importance of Hydrates
  •  Importance of Pharmaceutical Salts

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 4: Medicinal Chemistry Strategies

In the process of drug discovery and drug development of a new drug, different terms are associated to the substances that are studied at different platforms in the process. Only if a substance Satisfies for a certain level is it subjected to testing on the next level. The process starts with a compound which is a chemical substance of Known chemical structure and purity. There are many strategies developed in Medicinal Chemistry in the recent years for the development of new drug candidates. Compounds with specific binding properties and are active are referred to as ‘hits’ and are further approved; this includes verifying their chemical identity and purity and determining their binding properties in one or more secondary assays. The current meeting of chemistry conferences will be a multinational gathering and present major areas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, and Pharmaceutical Technology. 

  • ADCs – Targeted delivery
  • Immuno-oncology
  • Small-molecule targeting of RNAs
  • Preventative Toxicology
  • Molecules with predictable in vivo and safety profiles
  • Phenotypic screening
  • SBDD Case studies
  • Macrocyclic compounds

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 5: Pharmaceutical Formulations: Academic and Industry Perspective

Rapidly, medicine research are moving from ‘Big Pharma’ to small Biotech companies and start-ups. To succeed in this new environment, scientific skills are not just enough, employers and financiers also need to be in  confident that the people they are working with possess the entrepreneurial skills to grow and sustain a business effectively. Pharmaceutical formulation development enables development of robust and compliant formulations and resolve difficult challenges encountered during preclinical and clinical development.

 

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 6: Pharmaceutical Research and Development

Research and Development can be defined as the most innovative and experimental way to find new Drug molecule, so that a new medicine can be created to treat some diseases more effectively. Superior quality R&D work requires an excellent back up from what are called the support functions. These include analytical, information services and technology, intellectual property and regulatory affairs. These are some of the main considerations in Pharmaceutical Technology and for the development of new drug candidates. To execute that Companies invest highly on their scientists and lab research.

  • Challenges in Pharmaceutical Formulations
  • Scope of Pharmaceutical Research
  • Pharmaceutical Research & Development
  • Pharmaceutical Packaging and labeling
  • Pharmaceutical industry
  • Bioinformatics and Computational Biology
  • Pharmaceutical Technology Assessment
  • Quality assurance
  • Opportunities in Pharmaceutical Management
  • Pharmaceutical Chemistry

 

to increase the stock of knowledge including search of new molecules, synthesis and modification of known molecules and some methods to increase production rate by adopting diverse techniques. Superior quality R&D Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 7: Chemo genomics

Chemo genomics is an emerging field that combines the latest tools of genomics and chemistry and applies in the discovery of novel drug molecules thereby to target drug discovery. As there are almost infinite number of drug-like organic molecules, this seems to be an an impossible task. Chemo genomics, on the other hand can be defined as the Finding of classes of compounds or related libraries. These compounds work against families of functionally related proteins in the protein structure. Chemo genomics also covers the chemical-biological interactions and their systematic analysis. The current meeting of chemistry conferences will be a multinational gathering and topics are Discussed such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, and Pharmaceutical Technology.

  • Biomolecules
  • Preparation of Natural products
  • Metal Complexes creation
  • Asymmetric synthesis
  • Organometallic chemistry
  • Nucleotide chemistry
  • Chemogenomics and Chemical Biology for Target Identification and Validation
  • Assemblies of macrolide-mimetics
  • Spiro– medium- and large(macro) heterocyclic systems
  • Isosteric replacements of amino acids, di-/tri-peptides

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 8: Pharmaceutical Organic Chemistry

Organic chemistry  is the branch of science that deals with the structure, properties, composition, reactions, and synthesis of organic compounds that contains carbon as their lead atom. Carbon is the only molecule which can form infinite number molecules with other elements that make it so unique . Pharmaceutical industry heavily relies on organic chemistry because all the medicines to be developed has to be compatible with organics of homo sapiens.

  • Isomerism
  • Lead-oriented synthesis
  • Evaluation of enzyme inhibitors in drug discovery

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 9:  Drug Discovery Chemistry

The discovery of candidate drug targets is exhausting and challenging, requiring the rapid development of techniques to identify the difference genomic profiling in disease and normal conditions, which will help in  understanding of the mechanism of diseases and the development of potential drugs can be processed for treatment of the disease. Medicinal chemistry has increasingly involved microarrays to identify both key target genes and gene networks that can regulate the effectiveness of drugs. As compared with all the other phases in drug discovery, this stage is complex by the fact that the identified drug target must mollify a variety of standards to permit development to the next step.  Example, the target should be selectively present in the pathogen, i.e. medicinal chemistry along with the  coding genes of drug design target that are present across different pathogens and have no human homolog connection and therefore they represent striking target candidates for new broad-spectrum drugs. These important topics will be covered in this current multi international gathering to get a proper insight from the renounced people belonging to this field.

  • Fragment-Based Drug Discovery
  • Macrocyclics & Constrained Peptides
  • Biophysical Approaches for Drug Discovery
  • Small Molecules for Cancer Immunotherapy
  • Inflammation Inhibitors
  • Protein-Protein Interactions
  • GPCR-Targeted Drug Design
  • Blood-Brain Penetrate Inhibitors
  • Kinase Inhibitor Chemistry

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 10: Integrating Medicinal Chemistry into the Drug Discovery Process

Earlier, “Drug Delivery” was taken as a specialization in pharmacy for formulations of drugs. However, it is natural that organic, medicinal, materials, and Nano chemistry have now become deeply involved in the development of drug delivery systems. These approaches have helped a lot in the creation of drug conjugates that are new chemical entities. Now functional carbon nanotubes as well as designed polymers  are used as a vehicle for drug delivery is a novel approach to drug discovery. Medicinal chemistry and pharmaceutical chemistry are Domains of the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs). These topics will be deeply discussed in the conferences by the  multinational gathering of eminent personnal.

  • Drug Discovery Chemistry – where are we heading
  • Target Validation using Medicinal Chemistry tools
  • Optimizing hit to lead optimization quality and timescale
  • Best Practice Case Studies
  • Data for decision making
  • Protein Degradation Strategies
  • Future of Medicinal Chemistry

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 11: Pharmacokinetics and Pharmacodynamics in Drugs

Pharmacokinetics is specifically defined as the study of the time required for Drug absorption, Distribution, Metabolism, and Excretion. Clinical pharmacokinetics helps in the application of pharmacokinetic principles to the safe and effective therapeutic effects of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing  drug efficacy and decreasing toxicity to the least in the patient’s drug therapy. This knowledge of  scientific relation between drug concentrations and their pharmacologic responses has enabled Drug developers to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics laid down the relationship between Drug concentration at the site of action and its resulting effect, which also includes the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is noted down by that drug’s binding with a receptor.

  • Pharmacokinetic parameters
  • Pharmacodynamic parameters
  • Absorption of drugs
  • Distribution of drugs
  • Biotransformation/metabolism
  • Excretion of drugs
  • Pharmacodynamics

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 12:  Drug Design and Synthesis

Drug Design and synthesis is the process in pharmaceutical sciences to develop new drugs. Drug designing includes lot of computational, analytical and practical approaches to execute a new drug molecule,Normally it takes around 12-15 years to develop a new drug molecule. Now a days modern softwares and databases help pharmacists to develop a molecule in 3D and then screen it in different conditions to see its therapeutic effect and toxicity. Covid 19 Drugs are being synthesize using the same method but making it quick and most effective

  • Frontiers in Catalysis
  • Aggressive Bond Disconnections in Total Synthesis
  • Chemical Probes for Characterizing Biology
  • Synthetic Biology for Natural Products
  • Advances in Drug Discovery
  • Natural Product Discovery and Biosynthesis
  • Combining Synthesis and Biosynthesis to Construct Complex Molecules
  • New Directions in Antibiotic Discovery and Development
  • Accessing Complex Molecules
  • Structure-biodegradability relationship
  • Diversity-Oriented Synthesis

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

 

Track 13: Drug Development and Clinical Trails

Drug Development in a process of developing a new drug molecule for specific Diseases. This process is very time consuming and required knife edge precision as if any mistake is being detected by the FDA, the drug molecule will be rejected, as FDA controls the process of drug development in the pharmaceutical industry. After the successful synthesis of the new drug molecule, Clinical trials begins. Clinical trials are being done to find out that how this new drug is reacting in  in-vivo conditions. Clinical trials are of 2 types (1.) Preclinical trails that are being done on animals like mouse and horses (2.) Four phases of human clinical trials are being done within the time duration of 6-7 years to see that how this drug is going to react in humans, and if it is showing least toxicity than it will be introduced in the market.

  • Drug development..
  • Drug discovery.
  • Heterocyclic compounds.
  • Synthesis and functional properties of molecules.
  • Asymmetric synthesis.
  • Pre-Clinical Trails.
  • Human Clinical Trials.
  • Computational chemistry
  • Supra molecular chemistry

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 14: Nano medicine and Biomedical Applications

Nano medicine is the application of  nanotechnology in a healthcare atmosphere and the majority of  its benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Nowadays, Nano medicines  are being used  thought the global to improve the treatments and lives of patients suffering from a range of disorders including  Cancer, kidney disease, fungal infections, spiking cholesterol levels, menopausal symptoms, multiple sclerosis, asthma, chronic pain and emphysema.  With the Extensive Development in Nanotechnology along with the Biomedical Sciences  Nano medicine has the rising potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale with the development of biosensors. To create precise solutions for upcoming medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative is creating new Nano materials and expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

  • Scope of Nanomedicine
  • Novel drugs to Nano drugs
  • Nanomedicine for other disease
  • Nanomedicine for gastrointestinal tract (GI) diseases
  • Nanomedicine for CNS
  • Nanomedicine for blood disorders
  • Nanomedicine for lung diseases
  • Nanomedicine for cardiovascular diseases
  • Future aspects of Nano medicine
  • Nano drugs for herbal medicines and cosmetics

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

 Track 15: Chemical Synthesis and Catalysis

From drug synthesis to quality control (QC) monitoring of over-the-counter medications, metals are found in all phases of the drug development process. Many metal-based products are used as imaging agents, Metals containing products are heavily used in Excipients, tablets, buffering agents etc. Too much Metal can Cause unnecessary toxicity on that metals could be added from the machines used in pharmaceutical industry. To counter that lot of Catalysis techniques are being used to get rid of this problem.

  • Organocatalysis
  • Flow-chemistry approaches to the synthesis of key targets
  • Applications of organometallic compounds in synthesis and catalysis
  • Stereoselective synthesis
  • Synthesis and property of functional molecules and organic materials
  • Sustainable and Green synthetic and catalytic methods
  • Process development of key pharmaceutical targets
  • Synthesis in Medicinal chemistry and chemical biology
  • Biocatalysis in synthesis
  • Computational tools for synthesis and catalysis
  • Polymer synthesis

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

 

Track 16: Pharmacovigilance and Cosmetovigilance

Pharmacovigilance (PV or PhV), also described as drug safety of a drug when it is marketed, Pharmacovigilance is the part of the phase 4 of drug development which include the assessment, monitoring, collecting data, detecting errors, and prevention of adverse effects with pharmaceutical product. Pharmacovigilance can be defined as a surveillance on the market regarding the safety and efficacy of the drug, which are defined as any response to a drug which is adverse and lethal, which includes lack of efficacy (this happen when the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the changing of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, ,drug misuse,  abuse of a drug and drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Cosmetovigilance is the continuous and arranged surveillance of the safety of cosmetics in terms of human health. The aim is to detect negative and long term damaging effects of cosmetic products, and to prevent them by taking appropriate measures. Regulations for cosmetic products is at most necessary as cosmetic products are being used by large population on daily basis, but these regulations are currently industry driven and some industries take lot of privilege on that. It is the duties of the manufacturers to estimate that components and ingredients are safe before they are being introduced into the market, and then to collect reports of adverse reactions.

  • Regulation and prequalification
  • Clinical Drug Safety
  • Individual Case Safety Report

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 17: Bioorganic Chemistry

Widely defined, the domain of Bioorganic chemistry seeks an understanding of biological processes through the tools and principles of organic chemistry. Bioorganic chemistry can be defined as a disciplinary field which has its historical roots in broadly detailed mechanistic studies of enzyme along with coenzyme models. The field of bioorganic chemistry currently emphasizes more on the current topics like molecular recognition, encompassing mechanistic investigations of enzymes themselves, drug design. It also deals with study of drug action, problems in biosynthesis, protein engineering, molecular evolution, supramolecular chemistry, and many other allied subjects.

  • Structural and in-Silico Chemistry
  • Chemical Biology for Drug Discovery
  • Pain Medications and their SAR
  • Recent Advances in Targeting Autophagy
  • Advances in Synthesis and Medicinal Chemistry
  • Photo-redox Catalysis

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 18: Pharmacognosy and Phytochemistry

Phytochemistry is the study of phytochemicals in specifically plants and other natural sources. Phytochemicals are compounds that are derived from mainly plants and other natural sources. In other words the terms are often used to describe the large number of primary and secondary metabolic compounds found in plants. Phytochemicals have tendency to protect against insect attacks and diseases. They also possesses a number of protective functions for human beings also. Pharmacognosy is the study of medicines or raw drugs  that has being extracted from natural sources such as plants, microbes, and animals. It includes analysis of their biological, chemical, biochemical, and physical properties and then find the correct formulae to develop that drug.

  • Traditional Medicine
  • Clinical Pharmacognosy
  • Aromatic Medicinal Plants
  • Marine Drugs
  • Applied Plant Sciences

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences |Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 19: Recent Advances in Pharmaceutical Technology

The pharmaceutical industry contributes to an important size of total research in most developed countries. In Europe, for example, it represents about 13% of total R&D. In recent years, These  pharmaceutical companies have been blamed of utilize their resources mainly to minor improvements over existing medications that require short clinical trials and have a small risk of being unapproved. The support functions was an most important part of a large company’s R&D function but nowadays they are mostly outsourced under contract to external organizations specializing in a specific service, especially if these activities are not seen to offer a competitive advantage to the company. Medicinal chemistry and pharmaceutical chemistry are vast fields at the intersection of Medicine and a Drug Development, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or Bio-active molecules (drugs).

  • Recent Development of Pharmaceutical Materials
  • Recent developments In Pharmaceutics & Biopharmaceutics
  • Advancements in Pharmaceutical Biotechnology
  • Approaches in Pharmaceutical Nanotechnology
  • Innovations in Pharmaceutical Technology
  • Advancements in Pharmaceutical Manufacturing
  • Development in Pharmaceutical Engineering
  • Pharmacological Technology advances

 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

 

With all the Expert scientific people over the world focused on learning about Pharmaceutical Current and Novel trends and advanced strategies and Technologies emerging in Pharma and Chemistry research areas. This is a best globalised opportunity to reach the largest assemblage of participants from the Pharma and Chemistry community. We anticipate participants, renowned speakers, pharmacists/chemist and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community.

Pharmaceutical Chemistry 2021  is a 2-day event offering the Exhibition at venue to showcase the new and emerging technologies and Conduct presentations, distribute information, meet with potential scientists, make a splash with new drug developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing. World-renowned speakers, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

 

  • Eminent Scientific Professionals in Pharma and Chemistry
  • Faculty (Professors, Associate Professors, Asst. Professors)
  • Pharma and Chemistry Colleges & Training Institutes
  • Pharmaceutical and Chemistry Associations and Societies
  • Pharmaceutical Business Entrepreneurs
  • Manufacturing Pharmaceutical products Companies
  • Manufacturing Medical Devices Companies
  • Pharma and Chemistry Students
  • PhD Scholars, Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Research Institutes and members
  • CRO and DATA management Companies
  • Data Management Companies

 

There has been associate degree upsurge within the usage of advanced technologies, like high turnout, bioinformatics and combinatorial chemistry for higher drug candidate identification. Drug discovery has evolved considerably with rising technologies, serving to the method to become a lot of refined, accurate, and fewer time overwhelming. thanks to automation, multi-detector readers, imaging hardware and software package, high-throughput screening is one amongst the foremost wide used drug discovery technologies.

In recent years, there has been a rising demand for specialty medicines that's expected to ultimately influence the little molecule drug discovery market in a very positive manner, as most of the specialty medicines area unit tiny molecules.

The gradual rise within the health care expenditure regionally helps the new pharmaceutical technology advancement. though with high expenditure, there's a desire for redirecting the resources, the transition toward higher usability of health care expenditure for drug development is below progress.

Scope and Importance of Pharmaceutical Sciences:

The scope of pharmacy follow includes combining and dispensing medications, and it put together related to plenty of trendy services like patient care, clinical services, reviewing medications for safety and powerfulness, and put together providing and gaining the drug knowledge.

A Glance at Market of Pharmaceutical Sciences:

The power of worldwide pharma has been growing over the past year, keep with the annual survey conducted Worldwide. Throughout the last ten to fifteen years, deals among the worldwide Nutrition supplements market have seen associate degree exceptional spike. The pharmaceutical business may be a crucial player in United Kingdom, Great Britain and Northern Ireland. In 2017, the annual turnover of pharmaceutical product wholesalers among the uk was over forty 2 billion British pounds, whereas the income from the retail sales of pharmaceutical product amounted to just about five billion British pounds in 2015. the price among the manufacturing of pharmaceutical product came up to over four billion in 2019.

Growth potential

India (7.16), the U.S. (7.04) and China (6.81) area unit once more the countries highlighted as having the quickest growth potential. Respondents viewed their high growth domestic markets and increasing producing exports as successful. Federal Republic of Germany was seen as Europe’s key growth market. the largest movers in terms of growth potential compared to last year were the united kingdom, boosting its score by twelve.72%, followed by Italian Republic (+10.94%), the U.S. (+10.63%) and Japan (+9.56%).

 

Pharmaceutical Chemistry 2021, provides the participants with different modes or ways to participate under either ACADEMIC / STUDENT / BUSSINESS Category

  • SPEAKER (Oral Presentation) : 25-30 minutes (only one person can present)
  • SPEAKER (Workshop) : 45-50 minutes (more than 1 can present)
  • SPEAKER (Special Session) : 45-50 minutes (more than 1 can present)
  • SPEAKER (Symposium) : more than 45 minutes (more than 1 can present)
  • DELEGATE(only registration): Will have access to all the sessions with all the benefits of registration
  • POSTER PRESENTER:  Can present a poster and avail the benefits of delegate
  • REMOTE ATTENDENCE:  Can participate via VIDEO presentation or E-poster presentation
  • EXHIBITOR: Can exhibit his/her company’s products by booking exhibitor booths of different sizes
  • MEDIA PARTNER
  • SPONSOR
  • COLLABORATOR

For Researchers & Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group Registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor Booths
  •  Sponsorships opportunities
  •  Product launch
  •  Workshop organizing
  •  Scientific Partnering
  •  Marketing and Networking with clients

For more details about each mode, kindly contact: 
Scarlet Grant (Program Manager)
mail id: p[email protected]

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 26-27, 2021
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View

Media Partners